Page last updated: 2024-09-03

reboxetine and Syncope

reboxetine has been researched along with Syncope in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Großhennig, A; Heusser, K; Jordan, J; Luft, FC; May, M; Mehling, H; Schroeder, C; Sweep, FC; Tank, J; Wenzel, D; Zoerner, AA	1
Birkenfeld, AL; Diedrich, A; Jordan, J; Luft, FC; Mayer, AF; Schroeder, C; Tank, J	1

Trials

2 trial(s) available for reboxetine and Syncope

Article	Year
Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study. Clinical pharmacology and therapeutics, 2014, Volume: 95, Issue:6 Topics: Adolescent; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Benzazepines; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Double-Blind Method; Endpoint Determination; Heart; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Metoprolol; Morpholines; Muscle Proteins; Norepinephrine; Orthostatic Intolerance; Pacemaker, Artificial; Potassium Channels; Reboxetine; Stroke Volume; Sympathetic Nervous System; Syncope; Young Adult	2014
Norepinephrine transporter inhibition prevents tilt-induced pre-syncope. Journal of the American College of Cardiology, 2006, Aug-01, Volume: 48, Issue:3 Topics: Blood Pressure; Cross-Over Studies; Cyclobutanes; Double-Blind Method; Head-Down Tilt; Heart Rate; Humans; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Posture; Reboxetine; Syncope	2006

Article

Year

Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study.

Clinical pharmacology and therapeutics, 2014, Volume: 95, Issue:6

Topics: Adolescent; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Benzazepines; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Double-Blind Method; Endpoint Determination; Heart; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Metoprolol; Morpholines; Muscle Proteins; Norepinephrine; Orthostatic Intolerance; Pacemaker, Artificial; Potassium Channels; Reboxetine; Stroke Volume; Sympathetic Nervous System; Syncope; Young Adult

2014

Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.

Journal of the American College of Cardiology, 2006, Aug-01, Volume: 48, Issue:3

Topics: Blood Pressure; Cross-Over Studies; Cyclobutanes; Double-Blind Method; Head-Down Tilt; Heart Rate; Humans; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Posture; Reboxetine; Syncope

2006